Rapid Cas13a-based pen A genotyping for cefixime susceptibility in Neisseria gonorrhoeae

By afschroeder • May 20, 2026

Nguyen THY, Garg S, Adams G, Mantena S, Gopal N, Suk H-J, D Klausner J, Sabeti PC, Lemieux JE, Allan-Blitz L-T. Rapid Cas13a-based penA genotyping for cefixime susceptibility in Neisseria gonorrhoeae. mSphere. 2026 May 19:e0018226. doi: 10.1128/msphere.00182-26. Epub ahead of print. PMID: 42153664.

Tags: antimicrobial resistance, Cas13, cefixime, CRISPR, Infectious Diseases, Neisseria gonorrhoeae, point-of-care, Publications, resistance-guided therapy

The hantavirus question we are not asking

Hensley LE, Halbrook M, Hoff NA, Merritt S, Olinger GG, Skinner B, von Fricken ME, Kindrachuk J, Rimoin AW. The hantavirus question we are not[...]

Advanced HIV Disease at First Diagnosis in South Brazil Extended Beyond Traditionally Targeted Populations: A 10-Year Hospital-Based Study (2015-2024)

Hernandez CJ, Fonseca PM, Noal A, Zywica M, Cambou MC, Varella IRDS, Santos BR, de Melo MG, Nielsen-Saines K. Advanced HIV Disease at First Diagnosis[...]

Does AI know how to choose wisely? Do not trust and definitely verify when using generative AI in stewardship operations

Dora AV, Benjamin LN, Graber CJ, Branch-Elliman W. Does AI know how to choose wisely? Do not trust and definitely verify when using generative AI[...]